This document is an excerpt from the EUR-Lex website
Document 22024D0151
Decision of the EEA Joint Committee No 138/2021 of 23 April 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/151]
Decision of the EEA Joint Committee No 138/2021 of 23 April 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/151]
Decision of the EEA Joint Committee No 138/2021 of 23 April 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/151]
OJ L, 2024/151, 25.1.2024, ELI: http://data.europa.eu/eli/dec/2024/151/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Date of entry into force unknown (pending notification) or not yet in force.
Official Journal |
EN Series L |
2024/151 |
25.1.2024 |
DECISION OF THE EEA JOINT COMMITTEE No 138/2021
of 23 April 2021
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/151]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
(1) |
Commission Regulation (EU) 2020/2160 of 18 December 2020 amending Annex XIV to Regulation (EU) No 1907/2006 of the European Parliament and of the Council as regards the substance group 4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (covering well-defined substances and substances of unknown or variable composition, complex reaction products or biological materials, polymers and homologues) (1) is to be incorporated into the EEA Agreement. |
(2) |
Commission Implementing Regulation (EU) 2020/1771 of 26 November 2020 approving reaction mass of peracetic acid (PAA) and peroxyoctanoic acid (POOA) as an existing active substance for use in biocidal products of product-types 2, 3 and 4 (2) is to be incorporated into the EEA Agreement. |
(3) |
Commission Implementing Decision (EU) 2020/1765 of 25 November 2020 not approving chlorophene as an existing active substance for use in biocidal products of product-type 2 (3) is to be incorporated into the EEA Agreement. |
(4) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:
1. |
The following indent is added in point 12zc (Regulation (EC) No 1907/2006 of the European Parliament and of the Council):
|
2. |
The following points are inserted after point 12zzzzzzp (Commission Implementing Regulation (EU) 2020/1086):
|
Article 2
The texts of Regulation (EU) 2020/2160, Implementing Regulation (EU) 2020/1771 and Implementing Decision (EU) 2020/1765 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 24 April 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 23 April 2021.
For the EEA Joint Committee
The President
Clara GANSLANDT
(1) OJ L 431, 21.12.2020, p. 38.
(2) OJ L 398, 27.11.2020, p. 9.
(3) OJ L 397, 26.11.2020, p. 24.
(*1) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2024/151/oj
ISSN 1977-0677 (electronic edition)